Search the GHTC website
January 11, 2021

Research Roundup: NIAID begins new antibody trials, convalescent plasma may lower COVID-19 risk, and Pfizer vaccine appears effective against mutation

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

January 5, 2021

Six issues to watch in US global health R&D policy in 2021

2021 is shaping up to be an extraordinarily consequential year for US policy for global health and medical research, as a new presidential administration and Congress take charge against the backdrop of a global pandemic that has killed 1.6 million people worldwide and set back decades of progress in global health. As 2021 begins, here are some of the top policy issues GHTC will be tracking.

January 4, 2021

Research Roundup: AstraZeneca shot gets first authorization, WHO issues emergency validation for Pfizer vaccine, and second Ebola drug gets FDA approval

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

December 22, 2020

Devex features GHTC paper on COVID-19 impacts to R&D

Devex cited a report released by GHTC assessing the impact of the COVID-19 pandemic on global health R&D.